STAT· @statnews · X·· 4 小时前AI 评分38
AI 导读
Life Biosciences 昨日表示，三名青光眼患者现已接受其试验性细胞重编程药物的单次注射，未出现严重不良事件。https://trib.al/dhdFQgX
正文
Life Biosciences said yesterday that three glaucoma patients have now received a single injection of its experimental cellular reprogramming drug, with no serious adverse events. https://trib.al/dhdFQgX
来源：STAT · x.com